• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

对《YTHDF2缺失促进肝细胞癌炎症和血管异常化》一文的更正

Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.

作者信息

Hou Jiajie, Zhang He, Liu Jun, Zhao Zhenjun, Wang Jianye, Lu Zhike, Hu Bian, Zhou Jiankui, Zhao Zhicong, Feng Mingxuan, Zhang Haiyan, Shen Bin, Huang Xingxu, Sun Beicheng, Smyth Mark J, He Chuan, Xia Qiang

机构信息

Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.

Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210093, China.

出版信息

Mol Cancer. 2020 Sep 4;19(1):137. doi: 10.1186/s12943-020-01257-8.

DOI:10.1186/s12943-020-01257-8
PMID:32887624
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7650264/
Abstract

An amendment to this paper has been published and can be accessed via the original article.

摘要

本文的一篇修订已发表，可通过原始文章获取。

相似文献

1
Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.对《YTHDF2缺失促进肝细胞癌炎症和血管异常化》一文的更正
Mol Cancer. 2020 Sep 4;19(1):137. doi: 10.1186/s12943-020-01257-8.
2
Correction to: Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma.对《综合分析揭示肝细胞癌中的关键糖酵解调节因子》的更正
Cell Commun Signal. 2020 Oct 22;18(1):165. doi: 10.1186/s12964-020-00674-y.
3
Correction to: MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming.对《MiR-612通过HADHA介导的脂质重编程调节肝细胞癌的侵袭伪足》的更正
J Hematol Oncol. 2020 May 4;13(1):44. doi: 10.1186/s13045-020-00875-5.
4
Correction to: miR-3928v is induced by HBx via NF-κB/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3.对《miR-3928v由HBx通过NF-κB/EGR1诱导并通过下调VDAC3促进肝细胞癌恶性进展》的更正
J Exp Clin Cancer Res. 2020 Aug 21;39(1):165. doi: 10.1186/s13046-020-01655-2.
5
Correction to: Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of Prrx1.对《转移前生态位触发SDF-1/CXCR4轴并通过下调Prrx1促进肝细胞循环肿瘤细胞的器官定植》一文的更正
J Exp Clin Cancer Res. 2020 Jul 7;39(1):130. doi: 10.1186/s13046-020-01636-5.
6
Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma.更正：用于蛋白尿管理的尿蛋白：肌酐比值与24小时尿蛋白对比：来自乐伐替尼与索拉非尼治疗肝细胞癌的3期REFLECT研究的分析
Br J Cancer. 2019 Oct;121(7):625. doi: 10.1038/s41416-019-0534-2.
7
Author Correction: Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinoma.作者更正：肝细胞癌的病因、表现、管理及预后工具的演变
Sci Rep. 2020 Oct 23;10(1):18482. doi: 10.1038/s41598-020-75523-6.
8
Author Correction: Caveolin-1 promotes invasion and metastasis by upregulating Pofut1 expression in mouse hepatocellular carcinoma.作者更正：在小鼠肝细胞癌中，小窝蛋白-1通过上调Pofut1表达促进侵袭和转移。
Cell Death Dis. 2019 Jul 29;10(8):572. doi: 10.1038/s41419-019-1800-1.
9
Retraction Note: Endoplasmic reticulum stress triggers Xanthoangelol-induced protective autophagy via activation of JNK/c-Jun Axis in hepatocellular carcinoma.撤稿说明：内质网应激通过激活肝细胞癌中的JNK/c-Jun轴触发黄辛醇诱导的保护性自噬。
J Exp Clin Cancer Res. 2020 Aug 19;39(1):164. doi: 10.1186/s13046-020-01668-x.
10
Correction to: LncRNA NEAT1 mediates progression of oral squamous cell carcinoma via VEGF-A and Notch signaling pathway.对《长链非编码RNA NEAT1通过VEGF - A和Notch信号通路介导口腔鳞状细胞癌进展》一文的修正
World J Surg Oncol. 2020 Oct 27;18(1):276. doi: 10.1186/s12957-020-02050-z.

引用本文的文献

1
CMSS1: A RNA binding protein with pivotal roles in non-small cell lung cancer progression and prognosis.CMSS1：一种在非小细胞肺癌进展和预后中起关键作用的RNA结合蛋白。
BMC Cancer. 2025 Apr 14;25(1):688. doi: 10.1186/s12885-025-14044-9.
2
New horizons for the role of RNA N6-methyladenosine modification in hepatocellular carcinoma.RNA N6-甲基腺苷修饰在肝细胞癌中作用的新视野。
Acta Pharmacol Sin. 2024 Jun;45(6):1130-1141. doi: 10.1038/s41401-023-01214-3. Epub 2024 Jan 9.
3
Decoding mA mRNA methylation by reader proteins in liver diseases.通过读取蛋白解码肝脏疾病中的mA mRNA甲基化
Genes Dis. 2023 Apr 13;11(2):711-726. doi: 10.1016/j.gendis.2023.02.054. eCollection 2024 Mar.
4
The evolving landscape of N-methyladenosine modification in the tumor microenvironment.肿瘤微环境中 N6-甲基腺苷修饰的演变景观。
Mol Ther. 2021 May 5;29(5):1703-1715. doi: 10.1016/j.ymthe.2021.04.009. Epub 2021 Apr 9.
5
Emerging roles of RNA methylation in gastrointestinal cancers.RNA甲基化在胃肠道癌症中的新作用
Cancer Cell Int. 2020 Dec 7;20(1):585. doi: 10.1186/s12935-020-01679-w.

本文引用的文献

1
YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.YTHDF2 减少可促进肝癌中的炎症和血管异常化。
Mol Cancer. 2019 Nov 18;18(1):163. doi: 10.1186/s12943-019-1082-3.